Global Bifurcation Leader Tryton Medical, Inc. Announces Events At TCT 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tryton Medical, Inc., the leading developer of stents to treat bifurcation lesions today announced activities highlighting the latest data and experience with the Tryton Side Branch Stent at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT), taking place at the Walter E. Washington Convention Center Washington, DC. The company will exhibit in booth 1327.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC